Delivery Order SPE2DB24D3014-SPE2DB25FKTTH
- Not listed
- The Defense Logistics Agency awarded a $4,806.61 firm fixed price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Savella 100 mg, a medication primarily used for fibromyalgia treatment. The contract was competitively awarded without set-aside designation and is scheduled for completion by August 7, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded a $4,780.42 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Savella 25 mg, a medication used to treat fibromyalgia. This competitive, non-set-aside contract represents a firm fixed price delivery order with an ultimate completion date of October 31, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award is issued as a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $2,111.57 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Savella 100 mg, a neurological medication used in pain management. This competitive contract, issued on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a firm fixed price delivery order with no set-aside designation. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,152.26 to AmerisourceBergen Drug Corp for the supply of Savella 25 mg tablets (60-count) on October 29, 2025, with an ultimate completion date of October 30, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December...
- The Defense Logistics Agency awarded a $1,580.37 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Savella (milnacipran) 50 mg tablets in a 60-count quantity. This firm fixed-price delivery order, with an ultimate completion date of September 8, 2025, represents a competitively awarded, non-set-aside contract for pharmaceutical procurement. The medication will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $3,237.86 to AmerisourceBergen Drug Corp for Savella 100 mg tablets (60-count units) on August 13, 2025, with completion targeted for August 14, 2025. This firm fixed-price delivery order represents a non-competitive set-aside contract and will be fulfilled at the contractor's corporate office location in Conshohocken, Pennsylvania. Savella (milnacipran) is a serotonin-norepinephrine reuptake inhibitor indicated for fibromyalgia...
- The Defense Logistics Agency awarded a delivery order valued at $18,324.20 to AmerisourceBergen Drug Corp for the supply of Savella (milnacipran) 100 mg tablets in quantities of 60 units. This competitively awarded, firm fixed-price contract has an ultimate completion date of August 29, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $5,275.27 to AmerisourceBergen Drug Corp for the supply of Savella 50 mg tablets (60-count units). This firm fixed price contract, awarded on August 6, 2025, with an ultimate completion date of August 7, 2025, represents a non-set-aside competitive award. The contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Savella (milnacipran) is a centrally acting analgesic used primarily for...
- The Defense Logistics Agency awarded a delivery order valued at $1,094.34 to AmerisourceBergen Drug Corp for the supply of Savella (milnacipran) 50 mg tablets in a quantity of 60 units. This contract, designated as a firm fixed price delivery order, was awarded on September 17, 2025, with an ultimate completion date of September 18, 2025. The award represents a non-competitive, non-set-aside transaction and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $1,092.15 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Savella 50 mg tablets (60-count packages). This firm fixed-price, non-set-aside contract will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 19, 2025. The delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreement with the DLA....
- SPE2DB24D3014Indefinite Delivery Contract
- SPE2DB24D3014-SPE2DB25FKTTHDelivery Order
The Defense Logistics Agency awarded a $7,980.01 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Savella 50 mg, a medication used to treat fibromyalgia. Issued on June 18, 2025, with an ultimate completion date of June 20, 2025, this firm fixed-price contract represents a non-set-aside competitive award. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999 and running through December 2026. This comprehensive pharmaceutical prime vendor agreement enables the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs globally, including the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. AmerisourceBergen's consistent success in competing for federal medical procurement contracts demonstrates its capability to fulfill specialized pharmaceutical requirements across multiple therapeutic domains for the Department of Defense's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.0k | 6/18/25 |